Latest filing published 27 Mar 2026 for iBio, Inc., €2,183.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -57.9%Entry US$1.71 · Close 23 Oct 2026 US$0.72
- -8.8%Entry US$2.73 · Close at T+365 US$2.49
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Marc Banjak: trading record in brief
All filings by Marc Banjak on record concern iBio, Inc. We count 3 filings; the first trade dates from 10 January 2025 and the latest from 26 March 2026.
Every open-market trade on record is a purchase: 3 purchases worth €44k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2026: 2 purchases and no sales on the market.
A typical purchase (the median) is worth €18k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -2.3%. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 27 March 2026 with an open-market purchase (€2,183) in iBio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Marc Banjak
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,434 shares@ US$1.764.9% of flowCommon StockSEC:0001104659-26-036093:1Canonical exit: 24 Jun 2026 (T+90)
- 12,500 shares@ US$1.642542.2% of flowCommon StockSEC:0001104659-26-036093:0Canonical exit: 24 Jun 2026 (T+90)
- 9,191 shares@ US$2.7257.8% of flowCommon StockSEC:0001104659-25-003062:0Canonical exit: 10 Apr 2025 (T+90)
3 of 3 declarations